Golden Meditech Holdings Ltd (801) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
38
About the Report
About the Report
Summary
Golden Meditech Holdings Ltd (Golden Meditech) is a medical equipment provider that provides blood stem cells storage and hospital management solutions. The company provides autologous blood recovery systems. It offers hospital management, medical insurance administration and blood bank services, among others. Golden Meditech's products are used for blood purification, recovery and treatment, among others. The company also provides blood bank for cord blood stem cells storage, and investments in the healthcare industry. It markets its products through a network of distributors in China and Hong Kong. Golden Meditech is headquartered in Hong Kong.
Golden Meditech Holdings Ltd (801)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Golden Meditech Holdings Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Golden Meditech Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Golden Meditech Enters into Partnership Agreement with GE Healthcare 11
Golden Meditech and MD Anderson to Form Joint Venture 12
Equity Offering 13
Golden Meditech to Raise up to USD18 Million in Private Placement of Shares 13
Golden Meditech to Raise Funds through Rights Offering of Shares 14
Debt Offering 15
Golden Meditech Raises USD65 Million in Private Placement of 7% Notes Due 2017 15
Golden Meditech to Raises USD20 Million in Convertible Notes Offering 16
China Cord Blood Completes Private Placement Of Note For USD 50 Million 17
Acquisition 18
Nanjing Yingpeng Huikang Medical Acquires 65.4% Stake in China Cord Blood 18
Golden Meditech Plans to Acquire Remaining Stake in China Cord Blood 20
Golden Meditech to Acquire Remaining Stake in GM Hospital for USD21 Million 22
Golden Meditech Increases Stake In GM Hospital Group For USD 28 Million 24
Golden Meditech Holdings Ltd-Key Competitors 25
Golden Meditech Holdings Ltd-Key Employees 26
Golden Meditech Holdings Ltd-Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Joint Venture 28
Recent Developments 29
Financial Announcements 29
Jun 27, 2018: Golden Meditech Announces FY2017/2018 Annual Results 29
Jun 25, 2018: Golden Meditech Holdings: Positive Profit Alert 31
Nov 30, 2017: Golden Meditech Announces FY2017/2018 Interim Results 32
Jun 28, 2017: Golden Meditech Announces FY2016/2017 Annual Results 34
Corporate Communications 36
Apr 26, 2018: Golden Meditech: Re-designation of Directors and Changes of Members of Board Committees 36
Apr 16, 2018: Golden Meditech's Associate, Cellenkos Appoints Alick Sun as Corporate & Business Development SVP 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38
List of Figure
List of Figures
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Golden Meditech Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Golden Meditech Holdings Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Golden Meditech Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Golden Meditech Enters into Partnership Agreement with GE Healthcare 11
Golden Meditech and MD Anderson to Form Joint Venture 12
Golden Meditech to Raise up to USD18 Million in Private Placement of Shares 13
Golden Meditech to Raise Funds through Rights Offering of Shares 14
Golden Meditech Raises USD65 Million in Private Placement of 7% Notes Due 2017 15
Golden Meditech to Raises USD20 Million in Convertible Notes Offering 16
China Cord Blood Completes Private Placement Of Note For USD 50 Million 17
Nanjing Yingpeng Huikang Medical Acquires 65.4% Stake in China Cord Blood 18
Golden Meditech Plans to Acquire Remaining Stake in China Cord Blood 20
Golden Meditech to Acquire Remaining Stake in GM Hospital for USD21 Million 22
Golden Meditech Increases Stake In GM Hospital Group For USD 28 Million 24
Golden Meditech Holdings Ltd, Key Competitors 25
Golden Meditech Holdings Ltd, Key Employees 26
Golden Meditech Holdings Ltd, Other Locations 27
Golden Meditech Holdings Ltd, Subsidiaries 27
Golden Meditech Holdings Ltd, Joint Venture 28
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.